Abstract
Cachexia, a severe metabolic syndrome characterized by systemic inflammation and muscle wasting, affects approximately 50% of colorectal cancer (CRC) patients and significantly worsens prognosis. Despite its prevalence, the immunometabolic mechanisms linking cachexia and tumor progression remain poorly understood. Tumor-infiltrating lymphocytes (TILs) play a crucial role in regulating the…